EU in crisis as Britain looks set to vaccinate half of adults by weekend

Brexit Britain looks set to have delivered a first coronavirus vaccine jab to half of its adult population by the end of this week, as it continues outpacing the EU’s flailing roll-out programme.

Latest government figures show that the UK has already delivered a first jab to nearly 24.5m Brits, with over one and a half million getting a second dose that increases protection from the virus even further.


But NHS healthcare heroes are set to double the jabbing rate this week, with news that the supply of vaccines available to Britain has substantially increased.

But while Britain leads the western world in its jab roll-out, European Union countries are instead suspending the use of Britain’s brilliant Oxford/AstraZeneca wonder drug – in a move that boffins are calling “baffling”.

It’s now been reported that Portugal and Spain have joined the growing list of EU countries lashing out against the drug, even though global experts have confirmed that there is no evidence that it creates heightened risk of blood clots.

Many European countries have claimed to have suspended their use pending a meeting of the bloc’s medical regulator, but the EMA has already confirmed that blood clots “in vaccinated people seems not to be higher than that seen in the general population”.


Top German SDP politician Karl Lauterbach attacked Angela Merkel’s administration for her decision to block use of the jab, saying: “The suspension of vaccinations with AstraZeneca is a clear mistake. The complication rate with the vaccine is on the order of less than one in 100,000.”

But while the EU continues to cover up its procurement disaster by attacking British medicine, it was also reported at the weekend that the UK is currently on pace to have vaccinated all adults by early June, suggesting Britain could return to normal life much sooner than European counterparts struggling under the weight of Brussels bungling.

The claims of ill-informed European nations have already been comprehensively rebutted by a number of sources.

The jabmaker themselves have hit back, with an AstraZeneca spokesman saying: “In fact, the reported numbers of these types of events for COVID-19 Vaccine AstraZeneca are lower than the number that would have occurred naturally in the unvaccinated population.”

Professor Andrew Pollard, director of the Oxford boffin group who helped make the jab, also confirmed “very reassuring evidence that there is no increase in a blood clot phenomenon.”